LifeMD, Inc.

LFMD Healthcare Health Information Services

LifeMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $194.1 million, up 25.3% from fiscal 2024. In the quarter to June 2026, revenue fell 3.55%, EPS fell 166.7% and free cash flow fell 247.5%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

2.34 0.12 −4.88%
Market cap
$118.6M
P/E
0.0×
Fwd P/E
−17.9×
Dividend yield
—
F-score
6/9
Altman Z
−0.02
Beneish M
−3.67
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

4 6 8 5
ROE
913.95% 144.18% 34.95% (69.60%)
ROA
(17.07%) 15.35% 3.56% (4.35%)
ROIC
0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
90.99% 88.55% 58.54% 116.73%
Average Days of Receivables
20.23 17.50 18.61 21.44
Free Cash Flow per Share
0.07 (0.03) (0.08) (0.38)
Free Cash Flow
3.08 (1.24) (3.91) (18.28)
Capital Expenditures
(9.55) (9.52) (9.57) (8.37)
Other line items
Cash ROIC
11.35% (2.07%) (7.91%) (55.20%)
Accounts Receivable Turnover
21.82 19.64 19.29 20.62
Accounts Payable Turnover
1.65 2.21 1.37 1.13
Inventory Turnover
9.60 9.95 8.30 7.72
Average Days of Payables
244.56 186.34 309.89 276.72
Days of Inventory on Hand
42.93 36.53 45.47 45.05
Tax Rate
0.09 0.06 0.00 0.00
Research and Development Expense of Revenue
3.77% 3.79% 3.77% 3.78%
Selling, General and Administrative Expense of Revenue
70.86% 74.21% 78.85% 82.23%
Share Based Compensation of Revenue
6.56% 5.41% 4.86% 4.22%
Interest Coverage
(4.72) (3.79) (10.25) —
Operating CF/Net income
(1.07) 0.74 2.21 3.41
Depreciation/Fixed assets
3.12 3.09 3.43 3.88
Capex/Depreciation
(1.19) (1.26) (1.24) (1.06)
Revenue per Share
3.61 4.30 4.08 4.01
Operating CF per Share
0.27 0.18 0.12 (0.21)
Capex per Share
(0.21) (0.21) (0.20) (0.18)
Capex to Sales
0.06 0.05 0.05 0.04

Fold the line items

Columns are period end dates